These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

633 related articles for article (PubMed ID: 12960311)

  • 21. The MHC class I molecule H-2Dp inhibits murine NK cells via the inhibitory receptor Ly49A.
    Olsson-Alheim MY; Sundbäck J; Kärre K; Sentman CL
    J Immunol; 1999 Jun; 162(12):7010-4. PubMed ID: 10358142
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cis association of Ly49A with MHC class I restricts natural killer cell inhibition.
    Doucey MA; Scarpellino L; Zimmer J; Guillaume P; Luescher IF; Bron C; Held W
    Nat Immunol; 2004 Mar; 5(3):328-36. PubMed ID: 14973437
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MHC class I recognition by NK receptors in the Ly49 family is strongly influenced by the beta 2-microglobulin subunit.
    Michaëlsson J; Achour A; Rölle A; Kärre K
    J Immunol; 2001 Jun; 166(12):7327-34. PubMed ID: 11390483
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Quantifying the reduction in accessibility of the inhibitory NK cell receptor Ly49A caused by binding MHC class I proteins in cis.
    Andersson KE; Williams GS; Davis DM; Höglund P
    Eur J Immunol; 2007 Feb; 37(2):516-27. PubMed ID: 17236237
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ly-49P activates NK-mediated lysis by recognizing H-2Dd.
    Silver ET; Gong DE; Chang CS; Amrani A; Santamaria P; Kane KP
    J Immunol; 2000 Aug; 165(4):1771-81. PubMed ID: 10925254
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Augmentation of NK cell-mediated cytotoxicity to tumor cells by inhibitory NK cell receptor blockers.
    Tajima K; Matsumoto N; Ohmori K; Wada H; Ito M; Suzuki K; Yamamoto K
    Int Immunol; 2004 Mar; 16(3):385-93. PubMed ID: 14978012
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Class I MHC-binding characteristics of the 129/J Ly49 repertoire.
    Makrigiannis AP; Pau AT; Saleh A; Winkler-Pickett R; Ortaldo JR; Anderson SK
    J Immunol; 2001 Apr; 166(8):5034-43. PubMed ID: 11290784
    [TBL] [Abstract][Full Text] [Related]  

  • 28. IL-2 and IL-12 alter NK cell responsiveness to IFN-gamma-inducible protein 10 by down-regulating CXCR3 expression.
    Hodge DL; Schill WB; Wang JM; Blanca I; Reynolds DA; Ortaldo JR; Young HA
    J Immunol; 2002 Jun; 168(12):6090-8. PubMed ID: 12055219
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mapping the ligand of the NK inhibitory receptor Ly49A on living cells.
    Chung DH; Natarajan K; Boyd LF; Tormo J; Mariuzza RA; Yokoyama WM; Margulies DH
    J Immunol; 2000 Dec; 165(12):6922-32. PubMed ID: 11120818
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Positive impact of inhibitory Ly49 receptor-MHC class I interaction on NK cell development.
    Lowin-Kropf B; Held W
    J Immunol; 2000 Jul; 165(1):91-5. PubMed ID: 10861039
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A "chimeric" C57l-derived Ly49 inhibitory receptor resembling the Ly49D activation receptor.
    Mehta IK; Smith HR; Wang J; Margulies DH; Yokoyama WM
    Cell Immunol; 2001 Apr; 209(1):29-41. PubMed ID: 11414734
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Expression and significance of chemokine CXC receptor 3, 4 and their ligands at the early pregnancy decidua and villi].
    Bai XX; Kong BH; Zhang YZ; Qu X; Wang HL
    Zhonghua Fu Chan Ke Za Zhi; 2008 Dec; 43(12):904-8. PubMed ID: 19134328
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mouse Ly-49D recognizes H-2Dd and activates natural killer cell cytotoxicity.
    Nakamura MC; Linnemeyer PA; Niemi EC; Mason LH; Ortaldo JR; Ryan JC; Seaman WE
    J Exp Med; 1999 Feb; 189(3):493-500. PubMed ID: 9927511
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Expression of regulator of G protein signalling proteins in natural killer cells, and their modulation by Ly49A and Ly49D.
    Kveberg L; Ryan JC; Rolstad B; Inngjerdingen M
    Immunology; 2005 Jul; 115(3):358-65. PubMed ID: 15946253
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mouse Ly49 NK receptors: balancing activation and inhibition.
    Ortaldo JR; Young HA
    Mol Immunol; 2005 Feb; 42(4):445-50. PubMed ID: 15607796
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Coregulation of CXC chemokine receptor and CD4 expression on T lymphocytes during allogeneic activation.
    Ebert LM; McColl SR
    J Immunol; 2001 Apr; 166(8):4870-8. PubMed ID: 11290763
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ly49A inhibitory receptors redistribute on natural killer cells during target cell interaction.
    Eriksson M; Ryan JC; Nakamura MC; Sentman CL
    Immunology; 1999 Jun; 97(2):341-7. PubMed ID: 10447751
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impaired natural killing of MHC class I-deficient targets by NK cells expressing a catalytically inactive form of SHP-1.
    Lowin-Kropf B; Kunz B; Beermann F; Held W
    J Immunol; 2000 Aug; 165(3):1314-21. PubMed ID: 10903732
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of interaction between Ly49 inhibitory receptors and cognate MHC I molecules in IL2-induced development of NK cells in murine bone marrow cell cultures.
    Das A; Saxena RK
    Immunol Lett; 2004 Jul; 94(3):209-14. PubMed ID: 15275968
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Irradiation of breast cancer cells enhances CXCL16 ligand expression and induces the migration of natural killer cells expressing the CXCR6 receptor.
    Yoon MS; Pham CT; Phan MT; Shin DJ; Jang YY; Park MH; Kim SK; Kim S; Cho D
    Cytotherapy; 2016 Dec; 18(12):1532-1542. PubMed ID: 27720639
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 32.